A study reveals that lesion characteristics in geographic atrophy significantly influence growth rates, highlighting the need for targeted treatment strategies. The lesion characteristics of patients ...

Catch up on this week's highlights in retina. Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr Feistmann in an overview of office-based surgery, with actionable advice for retina specialists ...

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Feistmann in an overview of office-based surgery, with actionable advice for retina specialists ...

This study indicated that by analyzing the data of one of the most extensive GA patient cohorts in the Nordic countries, it established a data set on the long-term treatment-naive GA growth dynamics.

Belite Bio recently announced the acceptance of its New Drug Application (NDA) with priority review for tinlarebant by the Center for Drug Evaluation of China’s National Medical Products ...

While the STAR trial showed significant reductions in myopia progression, including over 50% in fast-progressing children, the FDA requires additional evidence to support US approval. Additionally, a ...

A recent study reveals that systemic chemotherapy significantly reduces mortality and enucleation rates in retinoblastoma, enhancing patient outcomes. A new study in the International Journal of ...

A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.

The newest research findings create "tangible benchmarks" for how earlier treatment can lead to better outcomes, said Dr. Kim. In an interview with Esther Lee Kim, MD, from Orange County Retina in ...

Philip J. Ferrone, MD, provided an overview of the TEASE 2 study (NCT02402660), a phase 2 clinical trial evaluating gildeuretinol in patients with moderate severity Stargardt disease, at the American ...